XERIS BIOPHARMA HOLDINGS, INC.
Last · NASDAQ$9.77-0.43 (-4.22%)close · yahoo · 9h ago
Market cap$1.78B182.3M sh
P/E · TTM-97.7fwd 26.4 · eps -0.10 · loss
Beta0.84vs S&P 500
Div yield0.00%annual · TTM
52w range
$5.25$11.33
Volume2.4Msession
| Revenue | $335.4M |
|---|---|
| Operating income | $13.1M |
| Net income | $-28.9M |
| Operating margin | 3.9% |
| Net margin | -8.6% |
| Period | TTM 2026-06-30 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-03-02
- Accumulated Deficit High
Red flags
- Accumulated Deficit High — Accumulated deficit / equity 4904%
Upcoming earnings
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.03
Est. revenue
101.7M